Stocks
State Street SPDR S&P Biotech ETFXBI
AMEXHealthcareBiotechnology$121.83-0.64%
An exchange-traded fund designed to track the performance of the S&P Biotechnology Select Industry Index, holding a broad basket of U.S.-listed biotechnology companies. The fund uses a modified equal-weight approach, giving smaller clinical-stage biotech firms greater representation than market-cap-...
Market Cap: $6.3B52W Range: $66.66 – $132.09
Congressional Interest in State Street SPDR S&P Biotech ETF (XBI)
7 members of Congress have disclosed 12 trades in State Street SPDR S&P Biotech ETF (XBI), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
7
Buys
7
Sells
5
Who in Congress Is Trading XBI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-16 | MIKE KELLY | sell | $1K – $15K |
| 2024-05-08 | Thomas H Tuberville | buy | $1K – $15K |